No significant reduction of CV events with aspirin in peripheral artery disease
Links shared publicly online about this topic.
- 2,046total visits
No significant reduction of CV events with aspirin in peripheral artery disease
A meta-analysis of trials assessing the effects of aspirin with or without dipyridamole in patients with PAD finds no significant benefit in reducing overall cardiovascular events, although there was a significant reduction in stroke as a secondary end point.
View full resource at theheart.org
Tags: Circulation, Circulatory Disorders, Peripheral Artery Disease, Stroke, Thrombotic Event, Disease and Condition, Aspirin
Most Recently Shared on May 13, 2009 at 9:25 pm By:
heartwire: No significant reduction of CV events with aspirin in peripheral artery disease http://bit.ly/aS6jA
Advertisement
